Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.55 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.46 |
| ▸ | SORD | Q00796 | 2/20 | 0.42 |
| ▸ | DPP4 | P27487 | 2/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.42 |
| ▸ | GRM4 | Q14833 | 3/20 | 0.37 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.37 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6281370 | 0.79 | HTR2C (0.65) | HTR2CHRH4SORDDPP4PRKCQ | |
| SCHEMBL6271843 | 0.79 | HTR2C (0.65) | HTR2CHRH4SORDDPP4PRKCQ | |
| SCHEMBL2076366 | 0.72 | HTR2C (1.00) | HTR2CHRH4SORD | |
| SCHEMBL30040877 | 0.72 | HTR2C (1.00) | HTR2CHRH4SORD | |
| SCHEMBL17865120 | 0.72 | HRH4 (0.46) | HTR2CHRH4SORDDPP4DPP7 | |
| Hydrochloric Acid SCHEMBL1532881 | 0.71 | HTR2C (0.97) | HTR2CHRH4SORD | |
| SCHEMBL17844907 | 0.70 | HTR2C (0.53) | HTR2CHRH4SORDDPP4DPP7 | |
| SCHEMBL30534241 | 0.69 | SCD (0.39) | PRKCQPRKCD | |
| SCHEMBL9881973 | 0.69 | PRKCQ (0.55) | PRKCQPRKCD | |
| SCHEMBL30614541 | 0.68 | HRH4 (0.56) | HTR2CHRH4SORDDPP4DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10369130-B2 | Antibacterial compounds | AZIEN DE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) | 2019-08-06 | — | — | US | disclosed |
| WO-2016096631-A1 | NEW ANTIBACTERIAL COMPOUNDS | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10369130-B2 | Antibacterial compounds | MRPL21, CLPP, NRDC | HTR2C 4816/4885HRH4 3610/4885SORD 1360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.